期刊文献+

乳腺癌新辅助化疗研究进展 被引量:7

下载PDF
导出
摘要 目的:探讨乳腺癌新辅助化疗的研究进展。方法:从乳腺癌新辅助化疗的概念、适应证、常用药物及方案、疗效预测因子及其与保乳手术、前哨淋巴结活检的关系等方面总结乳腺癌新辅助化疗的研究进展。结果:新辅助化疗可降低临床分期,增加保乳手术机会,了解化疗药物敏感性,防止远处转移,但对前哨淋巴结活检的影响存在争议。结论:新辅助化疗是乳腺癌全身治疗重要的部分,但在如何选择高效的化疗药物、制订个体化方案、预测治疗效果等方面仍需进一步研究。
作者 高云 刘广舒
出处 《医学理论与实践》 2013年第24期3250-3252,共3页 The Journal of Medical Theory and Practice
  • 相关文献

参考文献13

  • 1金贤英,全贞玉,韩春姬.1999~2008年恶性肿瘤住院患者的疾病构成分析[J].中国卫生统计,2011,28(1):107-108. 被引量:38
  • 2Chua S, Smith IE, A ' Hern RP, eta l. Neoadj uvant vinorelbine/ epirubicin(VE)versus standard adriamycin/cyclophosphamide (AC) in operable breast cancer breast cancer: analysis of re- sponse and toler ability in a randomised phase III trial(TOPIC2) [J]. Ann Oncol, 2005,16:1435.
  • 3Garber J, Richardson A, Harri L. Neoadjuvant cisplatin in tri- ple-negative breast cancer[J]. Breast Cancer Res Treat, 2006, 100, S1 : Abstr 3074.
  • 4Byrski T, Huzarski T, Dent R, et al. Response to neoadjuvant therapy with cisplatin in BRCAl-positive breast cancer patients [J]. Breast Cancer Res Treat, 2009,115 : 359.
  • 5Baselga J, Zambetti M, Llombart-Cussac A, et al. Phase II ge- nomics study of ixabepilone as neoadjuvant treatment for breast cancer[J]. J Clin Oneol,2009,27(4) :526.
  • 6Gianni L, Eiermann W, Semiglazov V, et al. Neoadj uvant chem- otherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer(the NOAH tri- al):a randomised controlled superiority trial with a parallel HER2-negative cohort [J]. Lancet, 2010,375 : 377.
  • 7Tashima R, Nishimura R. Changes in biological markers, par- ticularly hormone receptors, due to pre-operative chemothera- py(epirubicin/docetaxel) in operable breast cancer [J]. Oncol Rev,2008,2:229.
  • 8Andre F, Mazouni C, Liedtke C, et al. HER2 expression and ef- ficacy of preoperative paclitaxel/FAC chemotherapy in breast eaneer[J]. Breast Cancer Res Treat,2008,108(2) : 183.
  • 9Sullivan PS, Apple SK. Should histologic type be taken into ac- count when considering neoadjuvant chemotherapy in breast carcinoma? [J]. Breast J,2009,15(2) : 146-154.
  • 10Masuda H, Masuda N, Kodama Y, et al. Predictive factor for the effectiveness of neoadjuvant chemotherapy and prognosis in triple-negative breast cancer patients[J].Cance Chemother Pharmacol, 2011,67 (4) : 911-917.

二级参考文献4

共引文献37

同被引文献63

  • 1胡文娟,张蓓,潘玉林,谢蕴,刘维燕.磁共振灌注成像对局部进展期乳腺癌新辅助化疗疗效的评价[J].放射学实践,2011,26(1):25-29. 被引量:18
  • 2宋艳利,王东.新辅助化疗对Ⅱ期乳腺癌的疗效观察[J].中国肿瘤临床,2007,34(7):411-412. 被引量:7
  • 3杨正汉,冯逢,王霄英.磁共振成像技术指南[M].2版.北京:人民军医出版社.2010:96-102.
  • 4王晓稼.乳腺癌新辅助化疗的共识与争议[J].中国肿瘤,2007,16(10):788-792. 被引量:25
  • 5Van der Hage JA,Van de Velde CJ,Julien JP,et al.Preoperative chemotherapy in primary operable breast cancer:results from the European Organization for Research and Treatment of Cancer trial10902[J].J Clin Oncol,2001,19(22):4224-4237.
  • 6Fisher B,Anderson S,Bryant J,et al.Twenty-year follow-up of a randomized trial comparing total mastectomy,lumpectomy,and lumpectomy plus irradiation for the treatment of invasive breast cancer[J].N Engl J Med,2002,347(16):1233-1241.
  • 7Bluemke DA,Gatsonis CA,Chen MH,et al.Magnetic resonance imaging of the breast prior to biopsy[J].JAMA,2004,292(22):2735-2742.
  • 8Lyou CY,Cho N,Kim SM,et al.Computer-aided evaluation of breast MRI for the residual tumor extent and response monitoring in breast cancer patients receiving neoadjuvant chemotherapy[J].Korean J Radiol,2011,12(1):34-43.
  • 9Hylton NM,Blume JD,Bernreuter WK,et al.Locally advanced breast cancer:MR imaging for prediction of response to neoadjuvant chemotherapy—results from ACRIN 6657/I-SPY TRIAL[J].Radiology,2012,263(3):663-672.
  • 10Rakha EA, Ellis 10. Triple-negative/basal-like breast cancer: re-view[J]. Pathology, 2009,41: 40-47.

引证文献7

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部